About this trial
This study investigates the capabilities related to diet, physical activity, screening, and knowledge among diabetic adults with or without a history of hospital admissions in Central Florida. The hypothesis is that enhancing these capabilities, based on the Capability Approach framework, can significantly reduce hospital readmissions and improve diabetes management outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults over the age of 18.
Persons diagnosed with diabetes
Have an email account with access to a reliable internet connection or smartphone
Disqualifiers
Minors , ages under 18
Adults not diagnosed with diabetes
Adults who are unable to provide consent.
Trial population
Participants must be 18 years of age or older and diagnosed with diabetes to take part in this research study . Participants do not need to have ever been hospitalized to take part in this study. Participants will provide informed consent online and complete the survey online at their convenience. This study is available in English and Spanish.
Trial design
Case-only
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
The assessment of relationships between capabilities and health outcomes using the Structural Equation Modeling (SEM) based on the Capability Approach
The research employs a survey instrument with Likert-scale and open-ended questions, targeting diabetic adults with or without previous hospital admissions in Central Florida. Structural Equation Modeling (SEM) based on the Capability Approach will be used to analyze the data, allowing for the examination of relationships between capabilities (diet, activity, screening, knowledge) and health outcomes. The SEM will help identify the direct and indirect effects of these capabilities on diabetes management, providing insights into potential intervention points for improving health outcomes in this population.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Central Florida
Lead sponsor
AdventHealth
Collaborator